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Mechanistic understanding of the factors that govern host tropism
remains incompletely understood for most pathogens. Brucella
species, which are capable of infecting a wide range of hosts, offer
a useful avenue to address this question. We hypothesized that
metabolic fine-tuning to intrahost niches is likely an underappre-
ciated axis underlying pathogens’ ability to infect new hosts and
tropism. In this work, we compared the central metabolism of
seven Brucella species by stable isotopic labeling and genetics.
We identified two functionally distinct groups, one overlapping
with the classical zoonotic species of domestic livestock that ex-
clusively use the pentose phosphate pathway (PPP) for hexose
catabolism, whereas species from the second group use mostly
the Entner–Doudoroff pathway (EDP). We demonstrated that the
metabolic dichotomy among Brucellae emerged after the acquisi-
tion of two independent EDP-inactivating mutations in all classical
zoonotic species. We then examined the pathogenicity of key met-
abolic mutants in mice and confirmed that this trait is tied to vir-
ulence. Altogether, our data are consistent with the hypothesis
that the PPP has been incrementally selected over the EDP in par-
allel to Brucella adaptation to domestic livestock.
Brucella | metabolism | evolution | α-Proteobacteria
Mechanistic understanding of the factors that govern hostadaptations remains elusive for most pathogens. To in-
vestigate this central question, Rhizobiales are of particular in-
terest since they form an ecologically diversified bacterial order.
They include free-living organisms (e.g., Ochrobactrum and
Caulobacter spp.) as well as bacteria involved in different sym-
biotic relationships with eukaryotes, such as plant symbionts
(Rhizobium spp.) or pathogens (Agrobacterium spp.) and animal
pathogens (1). Among the latter, Brucella species are capable of
infecting a broad range of vertebrates and cause a widespread
zoonosis known as brucellosis (2, 3). Although other brucellae
can cause human infections sporadically (4), human brucellosis is
typically caused by species infecting domestic livestock (Brucella
abortus, Brucella melitensis, Brucella suis; biovars [bv.] 1, 3, and 4;
here, coined as classical zoonotic brucellae) and to a lesser ex-
tent by Brucella canis (5). Most Brucella species seem to have
emerged through explosive irradiation as they form a core group
separated from early branching species, like Brucella inopinata,
which itself is closer to soil-living Rhizobiales (6). Brucella thus
represent a remarkable model to investigate what makes a
pathogen successful in comparison with its phylogenetic neigh-
bors and the adaptations involved.
We hypothesized that metabolism fine-tuning to each niche is
likely crucial. Based on genome sequences, the central metabolic
network should similar in all Brucella species (7) and other Rhi-
zobiales (8, 9). It includes all enzymes of the pentose phosphate
pathway (PPP), Entner–Doudoroff pathway (EDP), Krebs cycle
(tricarboxylic acid cycle), and glyoxylate shunt (7–9) but lacks
classical glycolysis (Embden–Meyerhof–Parnas pathway [EMP])
because of the absence of 6-phosphofructokinase (Pfk) (see
Fig. 1A for metabolic interactions between PPP, EDP, and EMP)
(7, 10). Despite these similarities, the glucose catabolism of three
classical Brucella species was shown to rely exclusively on the PPP
for glucose catabolism (7, 11, 12), whereas Rhizobium, Agro-
bacterium, and Caulobacter species were experimentally shown to
exploit the EDP instead (8, 9, 13). The prominent use of the PPP
could, therefore, be a specific feature of the pathogenic Brucella
and may represent an important step in their adaptation to the
chemical landscape of the host.
Significance
Brucella species are capable of infecting a range of mammals,
including humans, with relative host specificity. We hypothe-
sized that metabolism is instrumental in host adaptation and
compared the central metabolism of seven species. We dem-
onstrate the existence of two distinct groups, including one
overlapping with the classical zoonotic brucellae of domestic
livestock that exclusively use the pentose phosphate pathway.
Species from the second group rely mostly on the Entner–
Doudoroff pathway instead. This metabolic dichotomy arose
after the acquisition of two newly identified EDP-inactivating
mutations. This selected trait seems to be linked to bacterial
pathogenicity in mice. The data fit the hypothesis that Brucella
has undergone a stepwise metabolic evolution in domestic
hosts that might also apply to other pathogens.
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Fig. 1. Central metabolism characterization of seven Brucella species by isotope profiling. (A) Simplified view of the metabolic interactions between the EMP,
EDP, and PPP. (B) Heat map representing the relative abundance of M0 and M + 1 fragments of isotopically labeled amino acids for seven Brucella species in
three different media (PG, PEG, and 2YT/5G). (C) Carbon fate map of [1-13C]glucose catabolized via glycolysis (blue), PPP (orange), or EDP (green). (D)
Theoretical serine- and alanine-labeling patterns resulting from each glycolytic pathway (Left) and observed patterns for tested Brucella species (Right). (E)
Estimations of pyruvate-synthesis fluxes via the different catabolic pathways. PPP contribution for glucose assimilation resulting in the absence of labeling
could only be estimated when glucose was the only C source (PG). Data represent the mean of biological triplicates ± SD when appropriate. Blank data
indicate the absence of growth in the tested condition (Dataset S1). M0, fraction having not integrated any 13C; M + 1, fraction having integrated one 13C;
M57, amino acid fragments [M-57]+ having conserved all C; M85 and M159, amino acid fragments [M-85]+ and [M-159]+ having lost the C1 during ionization.

















































To test this hypothesis, we compared the metabolism of seven
Brucella strains with different preferential hosts. We found that
classical zoonotic species uniquely rely on the PPP for hexose
catabolism, whereas the other species utilize both the PPP and
the EDP. Therefore, the latter are metabolically intermediary with
soil-associated Rhizobiales using only the EDP (7–9). We dem-
onstrated that the metabolic dichotomy among Brucellae emerged
after the acquisition of two independent EDP-inactivating muta-
tions in most classical zoonotic species (B. abortus, B. melitensis,
and most B. suis biovars) as well as in B. canis. We then confirmed
that this trait is linked to bacterial virulence in mice.
Results
Central Carbon Metabolism Functionality Discriminates Two Groups
of Brucella Species. To test if the use of mainly the PPP represents
a decisive step in the adaptation to the animal host, we compared
the metabolic functionality of seven Brucella strains with different
host preferences. Bacteria were grown in three different media of
incremental complexity, i.e., Plommet medium with glucose as
sole carbon source (PG), with both glucose and erythritol (PEG),
and the rich medium 2× yeast extract tryptone (2YT) diluted five
times and supplemented with glucose (2YT/5G). The glucose
added to each medium was labeled on carbon 1 ([1-13C]glucose)
and used to monitor and compare the metabolism between species
and media. Under growth-supporting conditions, proteinogenic
amino acids from exponentially growing bacteria were extracted
and their 13C labeling analyzed by gas chromatography–mass
spectrometry (GC/MS) (see Dataset S1 A and B for raw and
processed data).
Hierarchical clustering and principal component analyses
(PCAs) on the labeling data revealed the existence of two groups
of Brucella species (Fig. 1B and SI Appendix, Fig. S1). Indeed,
this clustering discriminates the strains of the classical zoonotic
species (cluster I) from strains belonging to other Brucella spe-
cies, including B. inopinata, which is phylogenetically closer to
free-living Rhizobiales (cluster II) (14, 15).
The major difference between clusters in all tested conditions
lies in the labeling profile of pyruvate-derived amino acids (see
SI Appendix for in-depth PCAs and interpretation of isotopic-
labeling data). This difference originated from distinct uses of
the PPP and EDP, resulting in specific 13C-incorporation pat-
terns (Fig. 1C). In classical zoonotic strains (cluster I), pyruvate-
derived alanine was virtually unlabeled ([M-57]+ M0 = 1;
Fig. 1D) in all tested conditions. The absence of labeling, even
when glucose was the only C source, demonstrates the exclusive
use of the PPP that releases 13C1 as 13CO2 (Fig. 1C). Conversely,
a substantial proportion of alanine in species of cluster II had
incorporated 13C, indicating that labeled glucose has been ca-
tabolized through either glycolysis (EMP) or EDP. These two
glycolytic routes yield pyruvate labeled at a different position
(Fig. 1C), and comparisons of alanine [M-57]+ (C1-C2-C3) and
[M-85]+ (C2-C3) fragments revealed that labeling was lost con-
comitantly at carbon 1. Strains from cluster II appear, therefore,
to use the EDP for glucose catabolism rather than the EMP
consistently with the absence of phosphofructokinase in Brucella
species. Estimations of the percentage of pyruvate derived from
[1-13C]glucose catabolism via the EDP confirm that it is a major
route only in strains from cluster II in all tested conditions
(Fig. 1E). Nevertheless, the PPP seems to remain active in these
strains as observed in PG.
In Vitro Growth of Key Metabolic Mutants Confirms the Metabolic
Dichotomy among Brucella Species. To confirm our observations,
we deleted the genes encoding the first enzyme specific of either
the PPP (gnd) or the EDP (edd) in reference strains of B. suis bv. 1
(cluster I) and B. suis bv. 5 and Brucella microti (both cluster II). B.
suis bv. 1 Δgnd was unable to grow with glucose as the sole carbon
source, whereas the Δedd strain did not display any growth defect
(Fig. 2A). B. suis bv. 1 thus exclusively catabolizes glucose through
the PPP. In contrast, gnd deletion had respectively little or no
effect on the growth of B. suis bv. 5 and B. microti. The Δedd
strains displayed, however, marked growth defects, thus confirm-
ing the importance of the EDP in strains of cluster II. Neverthe-
less, these Δeddmutants were still able to grow and therefore have
a functional PPP that partially compensates for the lack of EDP.
In summary, the phenotypes of key metabolic mutants confirm
the observations from isotopic-labeling data and demonstrate the
existence of two alternative central metabolism in Brucella spp.
Classical zoonotic strains catabolize glucose using only the PPP,
whereas those from cluster II (EDP + PPP) have a metabolism that
is intermediate with soil-associated α-Proteobacteria (EDP only).
Independent Mutations in edd Result in EDP Inactivation in Zoonotic
Brucella Species. We hypothesized that the metabolic shift in
classical zoonotic species originated from the inactivation of
Edd, the first enzyme of the EDP. Our reasoning was that 1) PPP
and EDP share the first two reactions catalyzed by enzymes
encoded in an operon along with edd in all species (Fig. 2B and
C); and 2) the expression of a functional Edd along with the
other genes of the operon would necessitate an active EDP to
prevent the toxic accumulation of the intermediate metabolite
2-keto-3-deoxy-6-phosphogluconate (16).
To investigate this hypothesis, we compared the edd sequence
of Brucella species and other α-Proteobacteria for which the use
of EDP has been experimentally demonstrated. This analysis
revealed the insertion of a seventh adenine within a stretch of six
that creates a frameshift (S407fs) in B. suis bv. 1 edd compared
with all of the other species. This insertion modifies 25% of the
Edd protein sequence on its carboxy (C)-terminal end (Fig. 2D).
To test the impact of the mutation, we tried to suppress B. suis
bv. 5 Δedd growth defect in PG by complementing with either the
endogenous gene or with a frameshifted copy from B. suis bv. 1
(Fig. 2E). Only the endogenous gene restored wild-type (WT)
growth, proving that the S407fs causes the loss of Edd function.
This frameshift is conserved in all sequenced B. suis strains (bv.
1, 2, and 3; n = 97) as well as in the related B. canis but not in B.
suis bv. 4.
In all B. abortus and B. melitensis sequenced, we identified a
conserved nonsynonymous mutation A178P (Fig. 2D). This
substitution introduces a proline in a β-strand predicted to be
deeply buried into the protein, likely resulting in enzyme inac-
tivation. Transcomplementation of B. suis bv. 5 Δedd with B.
abortus eddA178P and the reverted eddP178A showed that only the
latter restored growth on glucose (Fig. 2F). These results confirm
that the A178P mutation is responsible for Edd dysfunction and
thus for EDP inactivation in B. abortus and B. melitensis.
In summary, the exclusive use of the PPP observed in Brucella
strains from cluster I is consecutive to two independent muta-
tions inactivating Edd (S407fs and A178P), resulting in a non-
functional EDP in B. abortus, B. melitensis, B. canis, and B. suis
bv. 1, 2, and 3. As these inactivation events occurred indepen-
dently in different species, our finding supports that there was a
convergent evolution toward the exclusive use of the PPP in
these bacteria.
These observations further indicated that our B. suis bv. 1 Δgnd,
being a natural edd mutant, had both EDP and PPP pathways
inactivated. This is surprising since without Gnd, a functional Edd
and a Pfk for the otherwise interrupted EMP, there is no known
pathway left for hexose catabolism. It raises the hypothesis of an
unknown distinct metabolism or that compensatory mutations
might have paralleled the loss of a functional edd in this strain.
Nevertheless, the deletion of gnd in B. suis bv. 1 is not insignificant
since it results in a marked growth defect even in rich medium (SI
Appendix, Fig. S2). We tried to reproduce this genotype in B. suis
bv. 5 by doing a second round of homologous recombination to
delete gnd in the Δedd strain or edd in the Δgnd background. No









































double mutant could be obtained, demonstrating that these two
deletions are synthetic lethal in B. suis bv. 5 (P < 10−15 to delete
gnd and P < 3.10−5 to delete edd with a χ2 analysis assuming an
expected 50:50 distribution of WT and Δ genotypes post-
recombination). This synthetic lethality observed in B. suis bv. 5
being not conserved in B. suis bv. 1 highlights the existence of
other interspecies metabolic differences. The existence of such
differences is also supported by the strain-specific capability to
grow on the different media tested (Fig. 1B) and will need to be
further investigated.
The Exclusive Use of the PPP Alters the Outcome of B. Microti Infection
in BALB/C Mice. We hypothesized that the selection of the PPP
might indicate a selective advantage conferred in the context of
infection. Since it is virtually impossible to experimentally test the
virulence of our mutant strains in their native host, or to evaluate
Fig. 2. The metabolic switch of zoonotic Brucella species is due to Edd inactivation. (A) Growth on glucose of key metabolic mutants devoid of the EDP
(Δedd) or the PPP (Δgnd) with glucose. (B and C) Genes required for glucose catabolism through both PPP and EDP (zwf and pgl) are organized in a conserved
operon (gray) with edd. (D) Edd protein sequence comparisons highlighted the presence of a nonsynonymous mutation (A178P) conserved in B. abortus 2308
and B. melitensis 16M as well as a frameshift (S407fs) in B. suis bv. 1 and B. canis. A. fabrum, Agrobacterium fabrum; B. ceti, Brucella ceti; B. pinnipedialis,
Brucella pinnipedialis. (E and F) Complementation of B. suis bv. 5 Δedd growth defect in PG with the endogenous gene (pMR10-eddWT), the frame-shifted
gene from B. suis bv. 1 (pMR10-eddS407fs), the A178P mutated gene from B. abortus 2308 (pMR10-eddA178P) or the same gene with a reverted mutation
(pMR10-eddP178A). Data represent the mean ± SD (shaded area) of biological duplicates.

















































their zoonotic potential, we resorted to the mouse model of in-
fection. Typically, classical zoonotic brucellae are pathogens ca-
pable of setting sustained intracellular infections in natural hosts
that can be reproduced in the mouse model. In contrast, the same
doses of B. microti result in rapid clearance or lethality (17).
Therefore, there are three classes of Brucella at the intersection of
metabolism and virulence, those that use only the PPP (e.g., B. suis
bv. 1), those that use mostly the EDP (e.g., B. suis bv. 5) and cause
sustained infections, and those that use mostly the EDP and are
comparatively unable to persist (e.g., B. microti). We explored the
hypothetical link between hexose metabolism and virulence in
mice in a representative strain of each of these three classes.
Specifically, BALB/c mice were infected by WT, Δgnd, and Δedd
strains of B. suis bv. 1, B. suis bv. 5, and B. microti. As expected, the
deletion of the nonfunctional edd in B. suis bv. 1 did not affect the
number of colony-forming units (CFUs), whereas the Δgnd mu-
tant was significantly attenuated (Fig. 3A). These results demon-
strate the importance of hexose metabolism and of the PPP in vivo
in Brucella spp. belonging to cluster I. In B. suis bv. 5, the loss of
either gnd (PPP) or edd (EDP) had no impact on the infection
(Fig. 3B). In contrast, despite similar CFU numbers between B.
microti WT, Δedd, and Δgnd strains in the spleen (Fig. 3C), the
host survival kinetic was significantly modified dependent on
metabolism (Fig. 3D). The Δedd mutant relying only the PPP, like
classical zoonotic species, killed mice more rapidly and led to a lower
survival rate than the parental strain (Fig. 3D). The Δgnd mutant
turned out to have the opposite phenotype, being innocuous.
The disconnection between unmodified CFU counts and host
survival in B. microti indicates an altered immunogenicity in the
mutants rather than a difference in terms of replication. These
results demonstrate a direct but subtle link between the meta-
bolic switch described here and virulence in Brucella. Classical
zoonotic species have lost metabolic plasticity, which, similarly to
genome reduction, might represent a feature of pathogen spe-
cialization (10, 12). Then, the impact of B. microtimetabolism on
host survival supports that the downstream effects of the meta-
bolic switch impact the host–pathogen interaction. The differ-
ence observed between B. microti and B. suis bv. 5 infection
indicates, however, that this impact might be moderate as only
observable when the infection is lethal. This difference might
also indicate that other factors could be involved, such as subtle
qualitative and/or quantitative differences in the pathogen-
associated molecular patterns (PAMPs) that are known to be
critical for Brucella persistence in the host (18). If so, the selec-
tion of the PPP over the EDP would postdate other adaptation
mechanisms allowing induction of sustained infections, resulting
otherwise in excessive host death. B. microti and then B. suis bv. 5
might thus be representative of intermediate evolutionary steps
between EDP-dependent free-living α-Proteobacteria and PPP-
dependent zoonotic Brucella species.
Discussion
The red queen hypothesis posits that hosts and pathogens are
running a never-ending arms race imposing reciprocal selective
pressures (19). Each host might consequently impose unique
constraints on a pathogen that, in turn, might follow similarly
unique evolutionary trajectories. We here more specifically stud-
ied how bacterial metabolism has been adjusted relative to different
hosts by comparing the metabolic functionality of multiple Brucella
species scattered across their phylogenetic tree and with different
host preferences. We identified two main metabolic classes of
Brucella, species closer to soil-associated α-Proteobacteria that use
both EDP and PPP, and those that have evolved in contact with
domestic animals or their ancestors that rely only on a functional
PPP. Based on these observations, we propose a model of stepwise
central carbon-metabolism evolution in Brucella species. It starts
with the ancestor to all Brucellae being a free-living soil bacterium
(6) whose hexose catabolism was likely exclusively relying on the
EDP. This feature is conserved among other phylogenetically close
α-Proteobacteria living in soil (e.g., Agrobacterium tumefaciens and
Sinorhizobium meliloti) (8), freshwaters (e.g., Caulobacter crescentus
Fig. 3. Consequences of the metabolic switch during the intraperitoneal
infection of BALB/c mice. (A–C) Average splenic CFUs enumerated 3 and 7 d
postinfection with B. suis bv. 1 (A), B. suis bv. 5 (B), and B. microti (C). (D)
Survival kinetics of mice infected with B. microti. *P < 0.05; **P < 0.01.









































and Rhodobacter sphaeroides) (8, 13), or marine environments (e.g.,
Dinoroseobacter shibae and Phaeobacter gallaeciensis) (20). All of
these environments are oligotrophic and therefore favor the EDP
over the EMP or PPP because of its higher thermodynamic driving
force and reduced need for energy-costly enzymes to achieve the
same glucose conversion (21). Such a Brucella ancestor would have
then transitioned to a facultative intracellular lifestyle and meta-
bolically diverged by using both EDP and PPP. This property is
common to the most Brucella strains in cluster II, as described here.
At this stage, the ancestor might have also transitioned from a
poorly adapted pathogen like B. microti to a bacterium capable of
inducing sustained infections following a path including, notably, a
reduction of PAMPs, as proposed before (18). Later, the common
ancestor of B. abortus and B. melitensis, as well as the ancestor of B.
suis bv. 1, 2, and 3 (and therefore of B. canis), would have inde-
pendently acquired EDP-inactivating mutations (edd A178P and
S407fs, respectively). These mutations would finally account for the
PPP-exclusive metabolism described here in cluster I brucellae. An
exception within cluster I lineages is B. suis bv. 4, which seems to
possess a functional EDP based on edd and eda sequences. One
hypothesis is that the mutations have not taken place yet in this
strain because of a relatively short time of evolution in association
with reindeers, its preferential host. Considering the explosive ir-
radiation of core brucellae (6), we favor this hypothesis over the
possibility that there might exist host specificities that conditioned
the evolution of the pathogen.
Interestingly, the selection of the PPP over the EDP in path-
ogenic bacteria described here does not seem to be restricted to
Brucella as it seems to have also occurred in mycobacteria. The
nonpathogenic, soil-living Mycobacterium smegmatis was initially
described as possessing both functional EDP and PPP pathways
(22). Interestingly, we observed that in M. smegmatis, each
pathway is genetically encoded in dedicated operons, zwf-edd-eda
for the EDP and zwf-pgl-tkt-tal for the PPP. While the PPP-
associated operon is conserved, pathogenic mycobacteria capa-
ble of inducing sustained infections, such as Mycobacterium tu-
berculosis, have lost the EDP operon. Consistently, the loss of the
EDP operon provides a genetic rationale for the absence of EDP
activity detectable in another pathogen, Mycobacterium leprae
(23). These coincidences support the hypothesis of the existence
of an evolutionary trajectory bridging the loss of the EDP and
bacterial virulence that has been adopted by at least some im-
portant intracellular bacterial pathogens.
The rationale for the selection of the PPP over the EDP at the
expense of metabolic plasticity could rely on differences in en-
zyme robustness. The iron–sulfur cluster-containing Edd is sen-
sitive to both iron scarcity and reactive oxygen species, two
stresses encountered in host macrophages, rendering the EDP
less amenable for the infection context (24–26). A second,
nonexclusive, explanation for the selection of the PPP is the
difference in yields existing between the two pathways. The ab-
sence of Pfk in Brucella imposes that the PPP works as a cycle
(cPPP) (SI Appendix, Fig. S3) (1). Assuming 1) a purely catabolic
purpose with pyruvate as end product, 2) an NADP-dependent
glucose-6-phosphate (glucose-6-P) dehydrogenase, and 3) an
NAD-dependent 6-phosphogluconate dehydrogenase (27, 28),
the cPPP would yield three times more NADPH than the EDP.
In the context of infection, higher NADPH availability may be
advantageous to cope with oxidative stress. Consistently, while
mycobacteria accumulate glucose-6-P in normal growth condi-
tions, the pool is depleted in oxidative-stress conditions and has
to be metabolized through the PPP for optimal survival (29).
Another advantage of a PPP-specific metabolism might be an
increase in biomass precursor availability along with NADPH
that also drives anabolic reductions. The cPPP produces 5 out of
12 biomass precursors required, for instance, to synthesize aromatic
amino acids such as tryptophan. It would notably allow countering
the indoleamine 2,3-dioxygenase–dependent tryptophan depletion
observed in IFN-γ–activated macrophages, a strategy also adopted
by Listeria monocytogenes (30, 31).
In summary, the existence of a metabolic dichotomy among
brucellae indicates that a progressive metabolic transition has
occurred during the evolution of the classical zoonotic species.
Our hypothesis is that they have transitioned from an EDP-based
metabolism to using both EDP and PPP before conserving only
the PPP in fine. Remarkably, the PPP has been selected at least
twice during Brucella history and originates from the acquisition
of EDP-inactivating mutations. This argues for a link between a
PPP-based metabolism and the characteristic ability of classical
zoonotic species to cause sustained infections, which is sub-
stantiated by our mouse infection data. The latter data further-
more indicate that the consequences of losing the EDP might be
subtle and would postdate other traits associated with the ability
to establish their characteristic type of infection. This evolu-
tionary trajectory might also have occurred in intracellular
pathogens, as in M. tuberculosis or M. leprae. Finally, our results
illustrate that reshaping metabolism is crucial in host coloniza-
tion by pathogens. Moreover, we only focused on a single, major
metabolic adaptation, but there are many more to unveil as each
of the tested Brucella species appeared to have a unique
metabolic signature.
Material and Methods
Bacterial Cultures and Growth Measurements. The Brucella species used were
B. melitensis 16M, B. abortus 2308, B. suis bv. 1 str. 1330, B. suis bv. 5 str. 513,
B. microti CCM4915, Brucella neotomae 5K33, and B. inopinata B01. They
were grown at 37 °C in rich-medium 2YT (16 g/L Bactotryptone; 10 g/L yeast
extract; 5 g/L NaCl; Difco) or in a chemically defined medium adapted from
Plommet medium (32, 33) composed of 2.3 g/L K2HPO4, 3 g/L KH2PO4, 0.1 g/L
Na2S2O3, 5 g/L NaCl, 0.2 g/L nicotinic acid, 0.2 g/L thiamine, 0.07 g/L pan-
tothenic acid, 0.5 g/L (NH4)2SO4, 0.01 g/L MgSO4, 0.1 mg/L MnSO4, 0.1 mg/L
FeSO4, 0.1 mg/L biotin and supplemented with a defined C source (addition
of methionine 1 mM is needed for the growth of B. melitensis 16M in
Plommet medium). Chloramphenicol (20 μg/mL), kanamycin (Kan) (50 μg/
mL), polymyxin B (2 μg/mL), sucrose (5% wt/vol), and agar were added when
required. Cultures in the chemically defined medium were performed in
three steps: 1) 24 h of culture in 2YT; 2) dilution to an optical density (OD)
of 0.1 in the chemically defined medium and incubation for 16 h; and 3)
dilution to an OD of 0.1 in the defined medium after centrifugation and
removal of the supernatant.
For isotopic-labeling experiments, 2YT/5G was prepared by diluting five
times 2YT with distilled water and adding 2 g/L [1-13C]glucose (Cortecnet),
and PEG was prepared by supplementing modified Plommet with 1 g/L
[U-12C]erythritol and 2 g/L [1-13C]glucose, whereas PG was prepared by only
adding labeled glucose at the same concentration.
Growth kinetics experiments were performed by monitoring the OD (600
nm) during 48 to 96 h in an automated plate reader (Bioscreen C; Lab Systems)
with continuous shaking at 37 °C.
Proteinogenic Amino Acid Extraction and GC/MS Analysis. Bacteria were grown
in 2YT/5G, PEG, and PG in Erlenmeyer flasks. Volumes corresponding to at
least 1 mg of bacterial dry weight (DW) were sampled mid-log phase (OD600:
∼0.4) and stored at −80 °C until extraction. Pellets were washed twice with
an isosmotic solution of NaCl and hydrolyzed at 105 °C for 22 h with 50 μL/mg
DW of HCl 6N. Cell debris were removed by filtration (Ultrafree-MC
Centrifugal Filter Devices; Amicon) before lyophilization. Prior to measure-
ment, hydrolysates were dried under a nitrogen stream, and amino acids were
turned into their t-butyl-di-methyl-silyl derivates by incubation at 80 °C for
30 min with 50 μL of N-methyl-N-tert-butyldimethylsilyl-trifluoroacetamide and
50 μL of 0.1% pyridine in dimethylformamide (34). Derivatized samples were
then injected into a GC/MS system for labeling-pattern determination (Agilent
7890A and MSD 5979C; Agilent Technologies). Amino acid separation was per-
formed using an Agilent HP5MS capillary column (5% phenyl-methyl-siloxane
diphenylpolysiloxane; 30 m × 250 μm) with 1 mL·min−1 helium as a carrier gas
and the following temperature profile: 120 °C for 2 min, 8 °C·min−1 up to 200 °C,
and 10 °C·min−1 until 325 °C is reached. Finally, amino acids were ionized by
electron ionization (70 eV), fragmented, and detected using a triple-quadrupole
detector with inlet, interface, and quadrupole temperatures set at 250, 280, and
230 °C, respectively. Each labeling analysis comprised one measurement in scan
mode to check for isobaric-fragment overlays. Relative fractions of relevant mass

















































isotopomers were then determined in duplicate in selective ion monitoring
mode. Isotopomers [M-57] and [M-85] were the most used as they include all
carbons and all carbons but the first, respectively (35, 36). Steady-state labeling
pattern was therefore calculated as mean value of 18 measurements for every
investigated conditions (3 biological replicates, 3 samples, 2 technical duplicates).
Data were then corrected for naturally occurring isotopes as well as for the in-
oculum using IsoCor (37).
Glycolytic fluxes estimation. [1-13C]Glucose catabolism via the three glycolytic
routes (EMP/PPP/EDP) results in distinct triosephosphate-labeling patterns
(Fig. 1 C and D). This difference allows quantification of the contribution of
each pathway for glucose breakdown.
In PG, glycolytic fluxes were estimated similarly as previously described (20,
38). In brief, we estimated PPP contribution (%PPP) by comparing experi-
mental (exp) and theoretical (th) labeling patterns of alanine [M-57]+,
whereas glycolysis contribution (%EMP) was based on serine [M-85]+ frag-
ment. We finally evaluated EDP contribution (%EDP) by subtracting %EMP
and %PPP from total activity:
%PPP =   Ala[M − 57] +M0exp  – Ala[M − 57] +  M0EDP=EMPth
Ala[M − 57] +M0PPPth  – Ala[M − 57] +  M0EDP=EMPth
=  Ala[M − 57] +M0exp  –  0.5
0.5
  × 100
%EMP =   Ser[M − 85] +M0exp  –  Ser[M − 85] +  M0EDP=PPPth
Ser[M − 85] +M0EMPth  –Ser[M − 85] +  M0EDP=PPPth
=   Ser[M − 85] +M0exp  –  1−0.5   × 100
%EDP = 100 −%PPP −%  EMP.
For the conditions involving a mix of unlabeled substrates and [1-13C]glucose
(PEG, 2YT/5G), it is impossible to estimate the %PPP. Indeed, the lack of 13C
incorporation could result indiscriminately from either [1-13C]glucose ca-
tabolism via the PPP or the metabolism of the additional C sources. Similarly,
since the %EDP was directly calculated from the %PPP (equation), it could
not be estimated as previously. Instead, we used the percentage of C3
compounds having acquired a 13C on C1 and C3 as a metric for EDP and EMP
activities, respectively. Since it is reasonable to assume that only 50% of the
C3 compounds produced by both pathways are labeled, we multiplied these
percentages by 2:
%EMP =   Ser[M − 85] +M + 1exp  ×   2  ×   100
%EDP =  Ala M − 57[ ] +M + 1exp  – Ala M − 85[ ] +M + 1exp  ×   2  ×   100.
Both estimation methods yielded highly similar values in PG with a correlation
coefficient R2 > 0.99 supporting their consistency. Since estimations in PEG and
2YT/5G quantify the percentage of [1-13C]glucose-derived C3 compounds and
do not take into account the contribution of the unlabeled substrate(s),
obtained percentages are lower than in PG with %EMP + %PPP + %EDP <100.
Bioinformatics and Data Analyses.Hierarchical clustering was performed on all
isotopic-labeling data (mean of biological triplicates for each fragment;
Fig. 1B) using Euclidean distances and Ward’s method. To further charac-
terize intercluster metabolic differences, PCAs were carried out on centered
unscaled labeling data individually for each tested medium (SI Appendix)
using FactoMineR and Factoextra (39).
For Edd protein sequence comparisons, sequences from multiple Brucella
species along with other phylogenetically close α-Proteobacteria were
aligned using MUltiple Sequence Comparison by Log-Expectation (MUSCLE)
(40) and visualized using Jalview (41).
Construction of Deletion and Complementation Strains. The locus tag identi-
fiers and nucleotide sequences of the genes edd, eda, and gnd for B. abortus
2308, B. melitensis 16M, B. suis bv. 1 1330, and B. suis bv. 5 str. 513 are
provided in Dataset S2. Construction of in-frame clean-deletion strains Δedd
(BAB2_0458) and Δgnd (BAB2_0109) in Brucella species was done similarly as
previously described (32, 42). Briefly, sequences of 750 base pairs upstream
(up) and downstream (dw) the gene to delete were amplified by PCR using
the Phusion high-fidelity DNA polymerase (ThermoScientific) from genomic
DNA (see Dataset S3 for primer sequences). The two PCR products were then
separately ligated in an intermediate pGEM Easy plasmid digested with
EcoRV (Promega). Insert sequences were checked by sequencing (Beckman
Coulter Genomics) before excision and ligation of up and dw fragments in
an appropriately digested pNPTS138 suicide vector (KanR SucS). The latter
vector was introduced in Brucella species by conjugation with the S17-1
Escherichia coli donor strain. We selected vector insertion events with
kanamycin along with either nalidixic acid or polymyxin B to counter select
the E. coli donor strain. Plasmid excision was then selected using sucrose
sensitivity conferred by the sacB gene along with the loss of kanamycin re-
sistance. Gene deletion was finally checked by PCR using at least one primer
external to the construction.
For complementation constructs, deleted genes were PCR-amplified using
one pair of primers (Dataset S3) on the genomic DNA of different Brucella
species. We sequenced the amplicons before ligation as XhoI-BamHI inserts
in the low-copy episomal vector pMR10 (KanR). To revert the inactivated
A178P Edd to a functional protein (P178A), we built a complementation
vector after introducing a single point mutation. To do so, edd from B.
abortus 2308 was PCR-amplified as two partially overlapping PCR products
(edd_comp_f/edd_comp_P178A_r2 and edd_comp_P178A_f2/edd_comp_r)
with the corrective mutation in the floating end of primer f2. Both PCR
products were assembled during a third PCR using primers edd_comp_f and
edd_comp_r. We then sequenced the product before ligating it as an XhoI-
BamHI insert in the pMR10 vector.
BALB/c Mice Infection.We performed the procedures and handling of mice in
an Animal Biosafety Level 3 facility in compliance with current European
legislation (directive 86/609/EEC) and the corresponding Belgian law “Arrêté
royal relatif à la protection des animaux d’expérience du 6 avril 2010 publié
le 14 mai 2010.” The Animal Welfare Committee of the Université de Namur
(Belgium) reviewed and approved the complete protocols (Permit 05-
058 LE).
Female BALB/c mice (8 to 12 wk old) were intraperitoneally infected as
previously described (43). In brief, bacteria from an overnight culture in 2YT
were pelleted, washed with Roswell Park Memorial Institute Medium 1640,
and diluted in this medium. We injected 500 μL of suspension (105 CFUs) into
groups of at least six mice for each tested strain.
For CFU counting, mice were euthanized by cervical dislocation and CO2
euthanasia during the acute phase of infection, i.e., 3 and 7 d postinjection.
Spleens were isolated and homogenized in 1 mL of 1x phosphate-buffered
saline/0.1% Triton X-100. Homogenates were then serially diluted and
plated on tryptic soy agar plates. The Mann–Whitney U test was used to
identify significant differences in CFU counts.
Survival kinetics upon infection by B. microti strains were conducted
similarly as described previously (17). Animals’ well-being was followed
twice a day after infection for signs of distress and end points such as im-
paired motility, labored breathing, ruffled hair coat, hunching, prostration,
dehydration, and weight loss. Mice exhibiting multiple criteria with severe
symptoms were euthanized as previously described and were considered
nonsurvivors. The Gehan–Breslow–Wilcoxon test was used to highlight sig-
nificant differences in host survival kinetics.
Data Availability. All study data are included in the article and SI Appendix.
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